Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...

A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...

The far-reaching move could disrupt U.S. programs around the world, including a widely lauded effort to combat HIV worldwide that is credited with saving some 25 million lives, U.S. officials warned.

GSK drops one of 2 maturation inhibitors in HIV pipeline GSK also disclosed this morning that it had removed a capsid protein inhibitor for HIV called VH4004280 from its phase 2 pipeline.

Clinical trials testing efficacy of novel HIV treatments rely on analytical treatment interruption (ATI). Using data from 24 prospective studies, the authors here show that the virus becomes ...

Lenacapavir (Sunlenca) received FDA approval in late 2022 as the second injectable HIV medication. It is in a new class of drugs, called capsid inhibitors, meaning that it affects the shell that ...

It's also called fat redistribution. While it used to be more common with older antiretroviral (ART) treatments for HIV, better control of HIV and newer antiretroviral drugs make the development ...

Nearly half of the new human immunodeficiency virus (HIV) infections reported in the Philippines last year were among the youth, according to the Department of Health (DOH). DOH Assistant Secretary ...

UNAIDS has welcomed Wednesday’s emergency waiver from the United States Secretary of State that will allow the continuation of life-saving HIV treatment funded by the US across 55 countries worldwide.

A move by the Trump administration to freeze funding for the U.S.’s widely heralded international HIV/AIDS program is sowing uncertainty globally and putting countless lives at immediate risk ...

LONDON, Jan 28 (Reuters) - The Trump administration has moved to stop the supply of lifesaving drugs for HIV, malaria and tuberculosis, as well as medical supplies for newborn babies, in countries ...